Rhythm Pharma Gets $21M A Round to Target Obesity - XconomyThe potential riches for makers of obesity and diabetes treatments are irresistible to biotech entrepreneurs and investors. Rhythm Pharmaceuticals, a drug developer focused on these multibillion-dollar markets, has closed a $21 million Series A round
Abbott Laboratories’ cholesterol drug TriCor failed to significantly reduce the risk of heart attacks and strokes among diabetics in a large government-sponsored study, reinforcing doubts about the drug’s usefulness despite its popularity. The Read More About Diabetes
Soy products beat drugs for type 2 diabetes prevention? - Food ConsumerType 2 diabetes is an affluence disease and lifestyle including diet plays an essential role in the development of diabetes. One study published in the March 2010 issue of Journal of Nutrition suggests eating soy products and isoflavones may reduce Source: www.foodconsumer.org
Read More About Diabetes…
Stop this silent killer - Star-TribuneNearly six million Americans are unaware they have diabetes. Look around you. One in five Americans is at risk for type 2 diabetes; 7.4 percent of Wyomingites have diabetes. Could one of them be someone you love? For many people with type 2 diabetes Source: www.trib.com
1-diabetes-care.com Launches Diabetic Supply Information Site
XOMA 052 Phase 2 Trial Initiated in Type 1 Diabetes - TMCnetBERKELEY, Calif., Mar 12, 2010 (GlobeNewswire via COMTEX) — XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to Source: green.tmcnet.com
SDNN
Amylin, Lilly Diabetes Drug Faces Crucial FDA DecisionWall Street JournalNEW YORK (Dow Jones)–After years of anticipation, a long-acting version of diabetes drug Byetta, sold by Amylin …Diabetes decision fuels option actionoptionMONSTER Research (registration)Diabetes Drug Makers Move Before Ruling, Plus Fast Food NewsSeeking Alpha (blog)Amylin, Alkermes Sit in Suspense For FDA Verdict on Once-Weekly Diabetes DrugXconomyeMaxHealth -FavStocks […]
This week’s edition of the program dealt with juvenile obesity, its causes, and solutions. The terrific panel came from a variety At the same time juvenile onset of adult diabetes is increasing, with the havoc it plays on bodies over time. Read More About Diabetes
Bulletin board - March 12 - Abington MarinerWant a degree? Need to upgrade your skills? Do you work full time but don’t want to travel to Boston? Then maybe Curry College’s Plymouth campus of Continuing Education and Graduate Studies is for you. They have been servicing the local area for